These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36657038)

  • 21. 3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
    Ren Y; Zhao Q; Liu H; Huang Y; Wang Z; Cao X; Teh BS; Wen B
    BMC Cancer; 2014 Nov; 14():894. PubMed ID: 25432818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
    Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
    Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
    Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy.
    Yamada Y; Kollmeier MA; Pei X; Kan CC; Cohen GN; Donat SM; Cox BW; Zelefsky MJ
    Brachytherapy; 2014; 13(2):111-6. PubMed ID: 24373762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.
    Aluwini S; van Rooij PH; Kirkels WJ; Jansen PP; Praag JO; Bangma CH; Kolkman-Deurloo IK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1480-5. PubMed ID: 22285661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose-rate brachytherapy for facial skin cancer: Outcome and toxicity assessment for 71 cases.
    Renard S; Salleron J; Py JF; Cuenin M; Buchheit I; Marchesi V; Huger S; Meknaci E; Peiffert D
    Brachytherapy; 2021; 20(3):624-630. PubMed ID: 33685816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
    Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
    Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
    Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
    Pellizzon AC; Salvajoli J; Novaes P; Maia M; Fogaroli R; Gides D; Horriot R
    Int J Med Sci; 2008 Jun; 5(3):113-20. PubMed ID: 18566673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Dose Rate 192-Ir-Brachytherapy for Basal Cell Carcinoma of the Skin using a 3D Printed Surface Mold.
    Casey S; Bahl G; Awotwi-Pratt JB
    Cureus; 2019 Jun; 11(6):e4913. PubMed ID: 31417833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes.
    Laliscia C; Gadducci A; Fabrini MG; Barcellini A; Guerrieri ME; Parietti E; Ursino S; Morganti R; Cafaro I; Paiar F
    Oncol Res Treat; 2017; 40(11):697-701. PubMed ID: 29065399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial high-dose-rate brachytherapy in eyelid cancer.
    Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
    Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Toxicity and Local Response using Three Fractions of High Dose Rate (HDR) Brachytherapy for Curative Treatment of Carcinoma Cervix.
    Ali N; Qureshi BM; Abbasi AN; Hafiz A; Khan BM; Jangda AQ
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):974-979. PubMed ID: 33036685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
    Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
    Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients.
    Lee CT; Lehrer EJ; Aphale A; Lango M; Galloway TJ; Zaorsky NG
    Cancer; 2019 Oct; 125(20):3582-3594. PubMed ID: 31355928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
    Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
    Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma.
    Lin Y; Ouyang Y; Lu Z; Liu Y; Chen K; Cao X
    Front Oncol; 2019; 9():278. PubMed ID: 31134143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.